Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Wow

<< Previous

Bullboard Posts

Next >>

Comment by Weedman1on Apr 12, 2010 7:43pm

222 Views

Post# 16983698

RE: RE: RE: RE: RE: RE: RE: Wow

with regards to Linda's post, if 1.5 million comes in from EVR divided by 48 million shares gives us a .03 per share value on the company, not including the other properties involved...I have another 100K @.035.

Assuming these arethe flow thru shares being sold, once the decision is made to liquidate...there's no thought process, sell and move on regardless of price...my 2 cents here

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages